Author:
Panhard X.,Goujard C.,Legrand M.,Taburet A. M.,Diquet B.,Mentre F.,
Subject
Pharmacology (medical),Pharmacology
Reference32 articles.
1. Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease
2. 2MH Zhang, YK Pithavala, CA Lee, JH Lillibridge, EY Wu, TM Sandoval, RG Daniels, and BM Kerr . Apparent genetic polymorphism in nelfinavir metabolism: evaluation of clinical relevance . 12th International Symposium on Microsomes and Drug Oxidations.Montpellier, France1998 , Abstract 264.
3. Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities
4. Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection
5. Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献